SCHEMBL396258

SCHEMBL396258

CCN(CC)CC.COC(C)OCCl

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23795116 0.85
SCHEMBL129288 0.85
SCHEMBL19554731 0.73 MEN1 (0.33) LMNA
SCHEMBL26927692 0.71
SCHEMBL10934241 0.67
SCHEMBL646212 0.67 LMNA (0.32) LMNA
SCHEMBL7226276 0.67
SCHEMBL94330 0.66
SCHEMBL975871 0.65
SCHEMBL396257 0.65 THRB (0.33) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11925689-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same SERINA THERAPEUTICS, INC. (US) 2024-03-12 US disclosed
US-20220193243-A1 MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME SERINA THERAPEUTICS, INC. (US) 2022-06-23 US disclosed
US-11213588-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same SERINA THERAPEUTICS, INC. (US) 2022-01-04 US disclosed
US-20190134208-A1 MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME SERINA THERAPEUTICS (AL), INC. 2019-05-09 US disclosed
US-10166294-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same SERINA THERAPEUTICS, INC. (US) 2019-01-01 US disclosed
US-20160317673-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same SERINA THERAPEUTICS (AL), INC. 2016-11-03 US disclosed
US-20150273074-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same SERINA THERAPEUTICS, INC. 2015-10-01 US disclosed
US-20140066577-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same SERINA THERAPEUTICS, INC. (US) 2014-03-06 US disclosed
US-8501899-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same SERINA THERAPEUTICS, INC. (US) 2013-08-06 US disclosed
US-20120123055-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same SERINA THERAPEUTICS, INC. (US) 2012-05-17 US disclosed
US-8101706-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same SERINA THERAPEUTICS, INC. (US) 2012-01-24 US disclosed
US-20100330023-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same SERINA THERAPEUTICS, INC. (US) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160317673-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same ERBB3, ERBB2, PANK2 LMNA 4630/4885
US-20220193243-A1 MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME ERBB3, ERBB2, PANK2 LMNA 4630/4885
US-20100330023-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same ERBB3, ERBB2, PANK2 LMNA 4630/4885
US-10166294-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same ERBB3, ERBB2, PANK2 LMNA 4630/4885
US-20190134208-A1 MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME ERBB3, ERBB2, PANK2 LMNA 4630/4885
US-20150273074-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same ERBB3, ERBB2, PANK2 LMNA 4609/4885
US-11925689-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same ERBB3, ERBB2, PANK2 LMNA 4630/4885
US-11213588-B2 Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same ERBB3, ERBB2, PANK2 LMNA 4630/4885
US-20140066577-A1 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same ERBB3, ERBB2, PANK2 LMNA 4630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.